Ishares Nasdaq Biotechnology (IBB)

[catty]

Rusty - back up to $400 again if it keeps going.

[rusty8350]

That they are. Plenty of room to run too.

[catty]

rusty: Got back in after a long time out. Bios are ready for a big comeback.

[rusty8350]

Look at this goofy volume in after hours? 1 2 3 5 1 1 1 5 3 5 4 ........ ? What the

[RiverNorth]

We're due, a rebound very shortly imo

[Tincupx]

Like ever? Of course. Sooner than later in my opinion

[RiverNorth]

Anyone think we'll see $320! Again?

[dannyzee84]

Break this damn bull flag and get down below 250

[onthegreen]

Still no Strength even on Green Market Days.

[STOCKSEEK]

Looks like bottom is established.

[$Pistol Pete$]

$IBB Daily and Weekly Charts

[beebop_rocksteady]

Wooooooooowwwwww!

[someone1]

Beautiful setup for next week, support is strong here at the 260's just look at the weekly and closing green.my guess will close at 265 and move north ah and pre market monday morning

[someone1]

Reversal is underway, my guess will hold here and move up end of day and green next week. 10$ move 7p is good enough for a bounce in my books.
I just got in ubio though and use this for better confirmation

[Pro-Life]

Yes, CLEARLY... full blown azz beat-down underway...

link back...

[jones99]

$IBB held support well at $280's. Markets look stable for now. May go up next few weeks? Oil stop falling?

[Jumpinjackas]

There goes the quick move

[onthegreen]

Another 52 wk low. Oil/China 1st

[venturecapp]

Smart Money Highlights Oversold Stocks in Small Cap Biotechs - article mentions IBB

http://marketexclusive.com/smart-money-highlights-oversold-stocks-in-small-cap-biotechs/1495/

[jones99]

$IBB looks a mess. I don't want to imagine what happens if it loses 273, so look for 286, 292 and 301 above. Be ready for a quick move here

[Pro-Life]

Clearly, this is having it's azz beat down...

[ThetaTrader]

$IBB Technical Analysis

Link to video - click here to watch the technical analysis

[TREND1]

IBB XBI RYH XLV DAILY

[CDFallon5]

Congressional inquiry on price of drugs could weigh in on the $IBB tomorrow

[TREND1]

IBB WEEKLY

[TREND1]

IBB 10 MINUTES

[TREND1]

IBB FROM ART HILL 317 is key

[TREND1]

IBB WEEKLY

[TREND1]

IBB WEEKLY

[TREND1]

What Does 2016 Hold for This Closely-Watched Biotech ETF?

Will the IBB return to its high flying ways in 2016 or will the debate over drug prices drag this popular ETF down?

The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) is a quick and easy way to gain exposure to a wide variety of biotech and pharmaceutical equities listed on the NASDAQ. As an added bonus, this ETF is designed to limit the risk of major downward price movements by holding shares in over 140 companies, removing most, if not all, of the possibility of getting entirely wiped out by a single negative regulatory or clinical event.


The prognosis for the IBB in 2016
Based on the data above, the IBB looks primed to have another good year in 2016 -- that is, if the market continues its recent trend of paying a lofty premium for biopharma earnings. A more global view, though, paints a rather worrisome picture. These companies have paid staggering premiums to gain access to novel experimental products lately, causing their debt levels to soar. If things don't go exactly as planned, the biotech bull run could turn into a nightmare real quick because of these heavily leveraged balance sheets.

That's a risk I'm not personally willing to take at this juncture. My hunch -- and, mind you, it's only a hunch -- is that the biotech bubble is nearing its apex, meaning that it's probably time to start reducing your exposure to this industry in general. After all, it's quite telling that Regeneron, the only company expected to generate double-digit growth next year -- and that lacks a serious debt problem to boot -- is projected to do so based in large part on the launch of its new cholesterol-lowering drug Praluent. Revenues from new drug launches, in my experience, are extremely hard to predict, and these next-generation cholesterol drugs could certainly draw the ire of payers for a host of reasons.

All told, the sustainability of biopharma's rapid revenue growth is now in question because of the drug pricing debate, and the ginormous amount of leverage being used across the industry is worrisome to say the least.

[TREND1]

IBB DAY

[TREND1]

IBB 10 MINUTES

[TREND1]

IBB MONTHLY

[Pro-Life]

From NorthmanTrader.com Technical Charts:

http://northmantrader.com/technical-charts/

IBB:

https://northmantrader.files.wordpress.com/2015/11/ibb.png

[Roo5guy]

It's about to top and fall

[kingsransome]

$400+ soon,,rlyp,aqxp,ttph,mcur,kbio,rptp,apri all on their tear up myop

[Stratdan]

AMGN After Hours Just Received FDA Approval On Skin Cancer Virus Drug!!!!
Oh Shyte!!!!!! Rock and Roll!!!!!!!!

[Stratdan]

That is what I think we have in store us!!!!!!!

[rmjackson]

IBB could explode tomorrow..niceday today

[oldsport]

very bullish moves lately... converted my nice biib gains into ibb holdings..

[someone1]

Wow is all i can say, it moves up a bit and they just keep hammering it down. Hopefully moves up soon

[Stratdan]

Gathering Shorts!!!! LMAO!!!

[kingsransome]

nice retrace in all bios today,,hit the trend line for reversal,big swing$$$$

[Stratdan]

Over the next 2 Weeks we Are Going to Get a Nice BioTech Run!!

[Stratdan]

These Shorts Are Playing With FIRE!!!! We Have The MOJO!!!!!! Momentum!!!!!

[Stratdan]

Yes Sir The More Short The More Merrier!!!!!!!!!! LMAO!!!!!!!!

[kingsransome]

some short fund paid to put out a scare on btech again,its not gonna fool us all in for $328+ watch boy$$$

[Stratdan]

Who Ever Is Short Better F*cking Cover!!!!!!!! And We Know Who You Are!!!!!

[Stratdan]

Buy Every Single Share You Can At $300!!!!!!! You won't be Sorry!!!!!!!

[Jld3294]

Over the next 2 months the biotechs will report. IBB doesn't have a single report date.